Use of rituximab in glomerulopathies.
作者信息
Dias Cristiane Bitencourt, Woronik Viktoria
机构信息
Universidade de São Paulo, Faculdade de Medicina, Laboratório de Fisiopatologia Renal, São Paulo, SP, Brasil.
出版信息
J Bras Nefrol. 2022 Apr-Jun;44(2):145-146. doi: 10.1590/2175-8239-JBN-2022-E004.
Abstract
摘要
相似文献
1
Use of rituximab in glomerulopathies.利妥昔单抗在肾小球疾病中的应用。
J Bras Nefrol. 2022 Apr-Jun;44(2):145-146. doi: 10.1590/2175-8239-JBN-2022-E004.
2
[Use of rituximab in primary and secondary glomerulonephritis].利妥昔单抗在原发性和继发性肾小球肾炎中的应用
G Ital Nefrol. 2015 Nov-Dec;32(6).
3
Treatment of fibrillary glomerulonephritis with rituximab: a 12-month pilot study.利妥昔单抗治疗纤维状肾小球肾炎：一项为期 12 个月的初步研究。
Nephrol Dial Transplant. 2021 Jan 1;36(1):104-110. doi: 10.1093/ndt/gfaa065.
4
Successful treatment of C1q nephropathy with CD19 targeted Rituximab therapy.采用靶向CD19的利妥昔单抗治疗C1q肾病取得成功。
Nephrology (Carlton). 2017 Mar;22(3):265. doi: 10.1111/nep.12757.
5
Rituximab use in adult glomerulopathies and its rationale.利妥昔单抗在成人肾小球疾病中的应用及其原理。
J Bras Nefrol. 2020 Mar;42(1):77-93. doi: 10.1590/2175-8239-JBN-2018-0254. Epub 2019 Dec 20.
6
Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies.利妥昔单抗治疗膜增生性肾小球肾炎和C3肾小球病
Biomed Res Int. 2017;2017:2180508. doi: 10.1155/2017/2180508. Epub 2017 May 9.
7
C1q nephropathy in a patient complicated with nephrotic syndrome and refractory to steroid therapy.
J Microbiol Immunol Infect. 2020 Feb;53(1):183-185. doi: 10.1016/j.jmii.2019.06.005. Epub 2019 Jun 28.
8
[Successful rituximab treatment of recurrent glomerulonephritis associated with antibodies against the glomerular basement membrane].利妥昔单抗成功治疗与抗肾小球基底膜抗体相关的复发性肾小球肾炎
Internist (Berl). 2020 Apr;61(4):416-423. doi: 10.1007/s00108-020-00773-5.
9
CMV gastric ulcer in a patient with pauci immune crescentic glomerulonephritis on rituximab - a rare combination.利妥昔单抗治疗后出现巨细胞病毒相关性胃溃疡合并寡免疫性新月体肾小球肾炎——一种罕见的组合。
Postgrad Med. 2019 Nov;131(8):619-622. doi: 10.1080/00325481.2019.1667211. Epub 2019 Sep 17.
10
Anti-CD20 therapy and pauci-immune crescentic glomerulonephritis.抗CD20疗法与寡免疫性新月体性肾小球肾炎。
J Formos Med Assoc. 2017 Apr;116(4):215-216. doi: 10.1016/j.jfma.2015.12.003. Epub 2016 Jan 16.
本文引用的文献
1
Rituximab in glomerular diseases: a case series and narrative review.利妥昔单抗在肾小球疾病中的应用：病例系列和叙述性综述。
J Bras Nefrol. 2022 Apr-Jun;44(2):187-195. doi: 10.1590/2175-8239-JBN-2021-0120.
2
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases.KDIGO 2021肾小球疾病管理临床实践指南。
Kidney Int. 2021 Oct;100(4S):S1-S276. doi: 10.1016/j.kint.2021.05.021.
3
Rituximab Induces Complete Remission of Proteinuria in a Patient With Minimal Change Disease and No Detectable B Cells.利妥昔单抗使一名微小病变病且无可检测到的B细胞患者的蛋白尿完全缓解。
Front Immunol. 2021 Feb 8;11:586012. doi: 10.3389/fimmu.2020.586012. eCollection 2020.
4
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?利妥昔单抗在成人微小病变性肾病和局灶节段性肾小球硬化症中的应用：已知和未知的有哪些？
Autoimmun Rev. 2020 Nov;19(11):102671. doi: 10.1016/j.autrev.2020.102671. Epub 2020 Sep 15.
5
Rituximab use as induction therapy for lupus nephritis: a systematic review.利妥昔单抗用于狼疮肾炎诱导治疗：系统评价。
Lupus. 2020 Jul;29(8):892-912. doi: 10.1177/0961203320928412. Epub 2020 Jun 2.
6
Persistent CD-19 depletion by rituximab is cost-effective in maintaining remission in calcineurin-inhibitor dependent podocytopathy.利妥昔单抗持续清除 CD-19 可有效维持钙调磷酸酶抑制剂依赖的足细胞病缓解。
Nephrology (Carlton). 2019 Dec;24(12):1241-1247. doi: 10.1111/nep.13554. Epub 2019 May 1.
7
Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease.基于利妥昔单抗的免疫抑制方案在肾小球疾病患者中的感染并发症。
Clin Kidney J. 2017 Aug;10(4):461-469. doi: 10.1093/ckj/sfw101. Epub 2016 Nov 10.
8
The Evolving Role of Rituximab in Adult Minimal Change Glomerulopathy.利妥昔单抗在成人微小病变性肾小球病中不断演变的作用
Am J Nephrol. 2017;45(4):365-372. doi: 10.1159/000464475. Epub 2017 Mar 18.
9
Sphingomyelinase-like phosphodiesterase 3b mediates radiation-induced damage of renal podocytes.鞘磷脂酶样磷酸二酯酶3b介导辐射诱导的肾足细胞损伤。
FASEB J. 2017 Feb;31(2):771-780. doi: 10.1096/fj.201600618R. Epub 2016 Nov 11.
10
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.前瞻性观察性单中心队列研究评估利妥昔单抗联合霉酚酸酯治疗狼疮性肾炎而不使用口服皮质类固醇的疗效。
Ann Rheum Dis. 2013 Aug;72(8):1280-6. doi: 10.1136/annrheumdis-2012-202844. Epub 2013 Jun 5.
Zotero 插件